The Role of UICC Japan in the New Drug Development and UHC in Asia

被引：0
|
作者：
Iwasaki, Masaru [1 ]
机构：
[1] Univ Yamanashi, Kofu, Yamanashi, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IS9-6
引用
收藏
页码：1246 / 1246
页数：1
相关论文
共 50 条
  • [41] JAPAN'S NEW ADVANCE IN EAST ASIA
    不详
    FOREIGN AFFAIRS, 1935, 14 (01) : 158 - 159
  • [42] THE NEW SECURITY BOUNDARIES IN ASIA - JAPAN STRATEGY
    NISHIHARA, M
    EUROPA ARCHIV, 1994, 49 (04): : 109 - 115
  • [43] The Role of Japan in the EU's Vision of East Asia
    Chizhevskaya, M.
    CONTEMPORARY EUROPE-SOVREMENNAYA EVROPA, 2019, (01): : 113 - 119
  • [44] Drug Development: The role of innovation in drug development
    Jürgen Drews
    Stefan Ryser
    Nature Biotechnology, 1997, 15 : 1318 - 1319
  • [45] Analysis of the success rates of new drug development in Japan and the lag behind the US
    Hirai, Yuka
    Yamanaka, Yosuke
    Kusama, Makiko
    Ishibashi, Taro
    Sugiyama, Yuichi
    Ono, Shunsuke
    HEALTH POLICY, 2012, 104 (03) : 241 - 246
  • [46] Delays in psychiatric drug development in Japan
    Shimazawa, R.
    Kusumi, I.
    Ikeda, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (03) : 348 - 351
  • [47] Japan and Germany in drug development deal
    不详
    CHEMISTRY WORLD, 2006, 3 (11): : 16 - 16
  • [48] System for the orphan drug development in Japan
    Hirai, T
    MEDICINAL CHEMISTRY: TODAY AND TOMORROW, 1997, : 251 - 253
  • [49] Drug Development for Pediatric Population in Japan
    Komura, Junko
    DRUG METABOLISM REVIEWS, 2010, 42 : 102 - 102
  • [50] Delays in Neurological Drug Development in Japan
    Shimazawa, Rumiko
    Ikeda, Masayuki
    INTERNAL MEDICINE, 2011, 50 (15) : 1565 - 1568
12345